CORT
#810
Corcept Therapeutics Incorporated - Common Stock
113.8 8 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.61%
Monthly Change
-3.57%
6 month change
+229.51%
Year Change
+55.21%
Previous Close
116.9 3
Open
113.8 8
Low
113.8 8
High
113.8 8
Volume
109
Financials
- Market Capitalization 12.31 B
- Employee 730
- Founded 1998
- CEO N/A
- Website www.corcept.com
- Headquarter Delaware, United States
- FIGI BBG000BKJG33
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
42.44
Price to sales ratio
5.48
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 799 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 64.67 USD | -0.95% | -2.85% | +7.11% | +10.74% | 12.52 B USD | ||
| 809 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 533.76 USD | -1.83% | +3.24% | +9.77% | +26.00% | 12.33 B USD | ||
| 823 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 84.91 USD | -4.15% | -2.14% | -2.32% | +117.16% | 11.99 B USD | ||
| 826 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 105.35 USD | -1.47% | -2.53% | +26.64% | +57.71% | 11.96 B USD |
Frequently asked questions about Corcept Therapeutics Inc.
What is the Corcept Therapeutics Inc. stock price today?
The current price of Corcept Therapeutics Inc. (CORT) is 113.88. Over the past 24 hours, the stock has changed by -2.61%. Follow the CORT chart for real-time price dynamics.
What is the stock ticker of Corcept Therapeutics Inc.?
Corcept Therapeutics Inc. trades under the ticker CORT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Corcept Therapeutics Inc. stock going up?
CORT has changed by -5.54% over the last week, -3.57% over the last month, and +55.21% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Corcept Therapeutics Inc.?
Corcept Therapeutics Inc. currently has a market capitalization of 12.31 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Corcept Therapeutics Inc. earnings last quarter?
Last quarter, Corcept Therapeutics Inc. reported earnings of 0.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Corcept Therapeutics Inc. revenue for the last quarter?
Corcept Therapeutics Inc. reported quarterly revenue of 256.15 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Corcept Therapeutics Inc. net income for the last quarter?
Corcept Therapeutics Inc. reported net income of 42.99 M for the last quarter. The previous quarter showed -31.76 M, which means net income changed by +235.35%.
How many employees does Corcept Therapeutics Inc. have?
As of the latest available data, Corcept Therapeutics Inc. has 730 employees. Workforce size can provide additional context about the company's scale and operations.
What is Corcept Therapeutics Inc. EBITDA?
Corcept Therapeutics Inc. EBITDA is 42.16 M, and its EBITDA margin is 16.46%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Corcept Therapeutics Inc. stock?
You can buy Corcept Therapeutics Inc. (CORT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Corcept Therapeutics Inc. stock?
Investing in Corcept Therapeutics Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CORT chart and related analysis on metatrader.com as part of your research.